Article Details

One firm, two conflicting takes on Alnylam's HELIOS-B - STAT News

Retrieved on: 2024-06-25 14:23:57

Tags for this article:

Click the tags to see associated articles and topics

One firm, two conflicting takes on Alnylam's HELIOS-B - STAT News. View article details on hiswai:

Excerpt

AstraZeneca said Imfinzi improved overall survival in certain bladder cancer patients. Will Zepbound hamper CPAP sales? Experts are divided. Late ...

Article found on: www.statnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up